Shareholders' Equity (Details Narrative) - USD ($)	1 Months Ended	5 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2015	Sep. 30, 2014
Business acquisition, shares issued				10,000,000
Contribution of unproved oil and natural gas properties				$ 1,898,947
Common stock, other shares outstanding	2,500,000	2,500,000
Common stock, shares outstanding	12,500,000	12,500,000	12,524,286	12,500,000
Common stock issued as a result of conversion of Series A Convertible Preferred stock			24,286
Number of Options, Granted			0
Weighted Average Exercise Price, Grants			$ 0
Weighted Average Remaining Contractual Life (In Years)			4 years 11 months
Stock-based compensation expense		$ 11,088	$ 99,783
Intrinsic value of outstanding options			$ 420,000
Stock Compensation | Chief Executive Officer
Number of Options, Granted	600,000
Weighted Average Exercise Price, Grants	$ 0.70
Weighted Average Remaining Contractual Life (In Years)	6 years
Stock options, vesting terms	Of the total stock options, 400,000 vest equally over the next four years and 200,000 vest equally over the next two years.
Fair value of options, date of grant	$ 400,087
Fair value assumptions, expected lives	4.25 (four-year vesting) and 3.75 (two-year vesting) years
Fair value assumptions, risk-free interet rate	1.92%
Fair value assumptions, dividend yield	0.00%
Fair value assumptions, expected volatility	195.00%